Norman Schwartz

Part of Advanced Medical Technology Association, AdvaMedDx operates as a trade association representing diagnostics manufacturers. The company is based in Washington. The CEO of the American company is Scott Whitaker.

Part of Bio-Rad Laboratories, Inc., Bio-Rad AbD Serotec GmbH is a supplier and manufacturer of antibodies, reagents, and kits. The company is based in Puchheim, Germany. The German company offers a wide range of custom antibody services, including bulk antibody production, antibody conjugation, and hybridoma production and services. The company's Pioneer Antibody Discovery team of scientists and technical specialists is assigned to every project to ensure a bespoke service tailored according to each client's success criteria. The CEOs of the company are Norman D. Schwartz, Lee Keron Marles.

Part of Bio-Rad Laboratories, Inc., Bio-Rad Laboratories Ltd. engages in research and manufacture of healthcare industry products. The company is based in Watford, UK.

Bio-Rad Germany Holding GmbH engages in the acquisition, disposal, financing, holding, and management of direct and indirect participating interests in firms. It focuses on firms, which specialize in the production and distribution of medical, diagnostic, and other products. The company was founded on March 2, 2009 and is headquartered in Dreieich, Germany.

ImmunSYS, Inc. is a clinical stage biopharmaceutical company focused on the development of cancer immunotherapy products. The company was founded by Eamonn P. Hobbs and Charles J. Link Jr. in March 2018 and is headquartered in Fort Lauderdale, FL.

Part of Bio-Rad Laboratories, Inc., Bio-Rad Services UK Ltd. is a company that specializes in developing, manufacturing, and marketing innovative products for the life science research and clinical diagnostic markets. The company is based in Watford, UK. The British company's products are verified for quality, purity, and performance through certificates of analysis (COAs), which can be obtained by catalog number and lot or batch number.

Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020.

Bio-Rad SAS is a French company that specializes in developing and manufacturing products for the life science research and clinical diagnostic markets. The private company is based in Marnes-la-Coquette, France. The company's focus is on accelerating biopharmaceutical and biotherapeutic method, process development, manufacturing, release testing, quality control, and patient monitoring with resources and workflows. The company is committed to helping the scientific community change the world through innovative products. The company was founded in 2012. Norman D. Schwartz has been the CEO of the company since 2021.